Model
Edge
Alnylam Pharmaceuticals, Inc.
0001829252
Filing Type
4
Filing Date
3/24/2025
Updated
3/25/25, 2:10 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership